Kevin D. Dykstra

Statistics

Publications

Citations

1.3K

H-Index

Active since

1999

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of Michigan

Kevin D. Dykstra is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, medicinal chemistry, and chemistry.

ORCID

Publications per year

1999–2024

Publications

Late‐Stage Functionalization of Biologically Active Heterocycles Through Photoredox Catalysis

Daniel A. DiRocco, Kevin D. Dykstra, Shane W. Krska et al. · Angewandte Chemie International Edition · 2014 · 485 citations

Natural Sciences, Chemistry, Medicinal Chemistry +17

Chemistry informer libraries: a chemoinformatics enabled approach to evaluate and advance synthetic methods

Peter S. Kutchukian, James F. Dropinski, Kevin D. Dykstra et al. · Chemical Science · 2016 · 248 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +17

Photoredox-Catalyzed Hydroxymethylation of Heteroaromatic Bases

Chelsea A. Huff, Ryan D. Cohen, Kevin D. Dykstra et al. · The Journal of Organic Chemistry · 2016 · 141 citations

Natural Sciences, Chemistry, Medicinal Chemistry +14

Late‐Stage Functionalization of Biologically Active Heterocycles Through Photoredox Catalysis

Daniel A. DiRocco, Kevin D. Dykstra, Shane W. Krska et al. · Angewandte Chemie · 2014 · 118 citations

Natural Sciences, Chemistry, Medicinal Chemistry +17

Microscale High-Throughput Experimentation as an Enabling Technology in Drug Discovery: Application in the Discovery of (Piperidinyl)pyridinyl-1 <i>H</i> -benzimidazole Diacylglycerol Acyltransferase 1 Inhibitors

Tim Cernak, Nathan J. Gesmundo, Kevin D. Dykstra et al. · Journal of Medicinal Chemistry · 2017 · 84 citations · Full text

Pharmacy, Chemistry, Pharmacology +11

1–5 of 13